Team
Biotica’s management team brings broad experience of drug discovery, development and partnering.
| Robert Booth, BA, FCMA | |
| Director of Finance and Operations | |
Robert Booth joined Biotica as Director of Finance and Operations in October, 2009. Prior to Biotica he was CEO and CFO of Pronostics Limited, a spin-out of the University of Cambridge, where he made… |
|
| Matthew Gregory, PhD | |
| Director of IP and Project Management | |
Matthew Gregory manages the intellectual property and collaborative research on Biotica’s internal projects, a role he has held since 2005. Dr Gregory joined Biotica in 2003, having… |
|
| Edward Hodgkin, D.Phil | |
| Chief Executive Officer | |
Edward Hodgkin joined Biotica as CEO in August, 2007 after 12 years in the United States. He was previously President & Chief Business Officer at San Diego-based BrainCells, Inc., a biopharmaceutical… |
|
| Christine Martin, D.Phil | |
| Senior Director, Molecular Biology | |
Christine Martin has worked extensively on the biosynthesis of natural products. She gained a D.Phil under Professors Baldwin and Sutherland (Oxford, UK), studying penicillin biosynthesis. Dr Martin… |
|
| Melanie McCullagh, D.Phil, MBA | |
| Director of Business Development | |
Melanie McCullagh joined Biotica as Business Development Director in April 2008. She was previously at Antisoma, where she was instrumental in the 2007 licensing of ASA404 to Novartis in a deal worth… |
|
| Steven Moss, PhD | |
| Director of Natural Products Chemistry | |
Steven has over 10 years experience in applying the chemical biology of natural products to drug discovery. He joined Biotica in 2002 as a Research Scientist and prior to that spent 2 years as a Post… |
|
| Barrie Wilkinson, PhD | |
| Vice President of Research | |
Barrie joined Biotica in January 2001 and was Director of Natural Products Chemistry before taking on his current role in March 2009. Prior to Biotica he was a research scientist in the Bioprocess research… |
|